A novel dominant-negative PD-1 armored anti-CD19 CAR T cell is safe and effective against refractory/relapsed B cell lymphoma - Concepedia

Concepedia

Publication | Open Access

A novel dominant-negative PD-1 armored anti-CD19 CAR T cell is safe and effective against refractory/relapsed B cell lymphoma

DOI Full Paper Access

46

Citations

29

References

2021

Year

Xiaoqian Liu, Yuanfeng Zhang, Kaimin Li, Yinghui Liu, Junqing Xu, Junjie Ma, Licai An, Hui Wang, Xiaoxia Chu

Translational Oncology

References

	Year	Citations

Page 1